Deva Holding AS | DEVA - Kas Dan Setara

Keuangan

TRY

TRY 12.93B

TRY 775.92M

Biaya Penjualan

TRY 991.13M

TRY 9.13B

Kewajiban Lancar

TRY 6.43B

TRY 5.3B

Dividen - Hasil

0.18

TRY 820.88M

TRY 882.9M

Eps Laba Per Saham

TRY 2.92

Modal Dan Cadangan

TRY 5.79B

Laba Kotor Pada Penjualan

TRY 1.32B

Beban Bunga Utang

TRY 272.53M

TRY 559.97M

Kapitalisasi Pasar

TRY 14.1B

Batas Pemasukan

TRY 583.98M

Biaya Operasional

TRY 1.35B

Laba Operasional

TRY 964.87M

Modal Saham Biasa

TRY 200.02M

Pe Harga Untuk Laba

6.55

Pendapatan Penjualan

TRY 2.32B

Beban Penjualan Dan Administrasi

TRY 462.26M

Kreditur Perdagangan

TRY 809.81M

Debitur Perdagangan

TRY 3.03B

	Kas Dan Setara	Perubahan		Tanggal
Akebia Therapeutics	USD 162.64M		22.2M	2026-03
Alaunos Therapeutics	USD 354K		1.03M	2026-03
Avita Medical	AUD 10.24M		1.98M	2025-12
Deva Holding AS	TRY 775.92M		574.67M	2023-09
Dianthus Therapeutics	USD 627.67M		576.58M	2026-03
Ionis Pharmaceuticals	USD 1.92B		758M	2026-03
IQVIA Holdings	USD 1.95B		33M	2026-03
Moderna	USD 1.91B		687M	2026-03
Organon & Co	USD 1.12B		542M	2026-03
Revvity	USD 860.32M		59.54M	2026-03
Tectonic Therapeutic	USD 236.89M		16.9M	2026-03
Viatris	USD 1.8B		481.8M	2026-03
Xeris Pharmaceuticals	USD 111.75M		708K	2026-03